Purchase Order HHSD2002015M63191P
- Not listed
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract, valued at $145,412.23, is for the provision of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies, including the National Institutes of Health,...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $79,283.85 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to supply...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
- This is a $96,525.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and consumables. The contract is for the provision of a SEQUENCER device and does not have a set-aside designation. Illumina has previously held prime contracts and subcontracts across federal agencies, including the National Institutes of Health, U.S. Department of Agriculture, and Department of Veterans Affairs,...
- This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
- This is a $101,594.39 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has an existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, and has received prior federal contract...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of a NextSeq sequencing system and has a ceiling value of $230,845.58. The contract has a period of performance ending on September 30, 2024. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $95,931.00 contract is for the provision of laboratory equipment, with no set-aside designation used. Based on Illumina's prior federal contract work, the equipment is likely to include NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and bioinformatics products to support genomic sequencing and analysis for research and diagnostics purposes across various federal agencies. While this appears to be a standalone contract award, Illumina also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide sequencing platforms and supplies for biological threat characterization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.9k | 6/16/15 |